Skip to main content

Cancer Biomarkers

Promotes research to identify, develop, and validate biological markers for early cancer detection, risk prediction, and prevention. Supports development of collaborative databases and informatics systems, advancement of new technologies, and refinement of existing technologies.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Evans Williams, Felicia, M.B.A. felicia.evanslong@nih.gov 240-276-5076	5E636	Program Analyst \| Cancer Biomarkers
	Fu, Sidney, M.D. sidney.fu@nih.gov 240-276-6669	5E134	Program Officer \| Cancer Biomarkers
	Hodges, Nicholas, Ph.D. nick.hodges@nih.gov 240-276-7844	5E616	Program Officer \| Cancer Biomarkers
	Kohaar, Indu, Ph.D., M.Phil., M.Sc. indu.kohaar@nih.gov 240-620-0875	5E612	Program Officer \| Cancer Biomarkers
	Krueger, Karl, Ph.D. [V] karl.krueger@nih.gov		Volunteer \| Cancer Biomarkers
	Marquez, Guillermo, Ph.D. guillermo.marquez@nih.gov 240-276-7035	5E132	Program Officer \| Cancer Biomarkers
	Orr, Susan susan.orr@nih.gov 240-276-5001	5E626	Program Support Assistant \| Cancer Biomarkers
	Patriotis, Christos, Ph.D., M.Sc. christos.patriotis@nih.gov 240-276-7134	5E614	Deputy Chief \| Cancer Biomarkers
	Petruzzelli, Angie angie.petruzzelli@nih.gov 240-276-5076	5E624	Program Support Assistant \| Cancer Biomarkers
	Srivastava, Sudhir, Ph.D., M.P.H. sudhir.srivastava@nih.gov 240-276-7028	5E136	Chief \| Cancer Biomarkers
	Villanueva, Juan Miguel juan.villanueva@nih.gov	5E630	Program Analyst \| Cancer Biomarkers
	Wang, Wendy, Ph.D., M.Sc. wendy.wang@nih.gov 240-276-7117	5E566	Program Officer \| Cancer Biomarkers
	Young, Matthew, Ph.D. matthew.young@nih.gov 240-276-5846	5E610	Program Officer \| Cancer Biomarkers

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Sen, Subrata	University Of Tx Md Anderson Can Ctr United States	Circulating Biomarkers and Imaging for Early Detection of Pancreatic Cancer	5U01CA214263-07	Matthew Young, Ph.D.
Shah, Sohrab P	Sloan-Kettering Inst Can Research United States	Exploiting markers of genomic instability in high-risk pre-invasive ovarian cancer	5R01CA281928-03	Christos Patriotis, Ph.D., M.Sc.
Shain, Alan Hunter	University Of California, San Francisco United States	Pre-cancer atlas of skin cancer	4U01CA294536-02	Nicholas Hodges, Ph.D.
Shalon, Tidhar Dari	Envivo Bio Inc United States	Development and clinical evaluation of the CapScan gastrointestinal sampling device for metabolomics monitoring	5R33CA260665-04	Amit Kumar, Ph.D.
Shelby, Rebecca A	Duke University United States	Improving outcomes for women experiencing premature or early menopause after cancer: development and pilot testing of a novel intervention	1R21CA301298-01	Goli Samimi, Ph.D., M.P.H.
Shelby, Rebecca A	Duke University United States	Persistent Post-Mastectomy Pain: Randomized Clinical Trial of Targeted Pain Coping Skills Training (Targeted-PCST) with Mediational Analysis	5R01CA249959-05	Brennan Streck, Ph.D., RN, M.P.H.
Shiozawa, Yusuke	Wake Forest University Health Sciences United States	Contribution of cutaneous neuro-immune interactions to chemotherapy-induced peripheral neuropathy	1R21CA297068-01	Rachel Altshuler, Ph.D.
Shirwan, Haval	University Of Missouri-Columbia United States	Developing a novel agonist of CD137 for cancer immunoprevention	5UG3CA290305-02	Altaf Mohammed, Ph.D.
Shu, Xiao-Ou	Vanderbilt University Medical Center United States	Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer	5R01CA227133-05	Matthew Young, Ph.D.
Shureiqi, Imad	University Of Michigan At Ann Arbor United States	ALOX15 regulation of colon cancer invasiveness via PI3P-linoleic acid metabolism	5R01CA266223-04	Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Siddique, Shahzad	Commonspirit Health Research Institute United States	CIRI Oncology Research Alliance	3UG1CA189809-11S1	Vanessa A. White, M.P.H.
Sidransky, David	Johns Hopkins University United States	Racial differences in Immunogenetic Tumorigenesis of Head and Neck Squamous Cell Carcinoma	5R01CA265975-04	Wendy Wang, Ph.D., M.Sc.
Sieren, Jessica C	University Of Iowa United States	Lung cancer screening efficacy enhanced through radiomic and epigenetic biomarkers	5R01CA267820-03	Nicholas Hodges, Ph.D.
Sigel, Keith Magnus	Icahn School Of Medicine At Mount Sinai United States	The effectiveness of screening women with lower genital tract neoplasia or cancers for anal cancer precursors	4R01CA256660-05	Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Simeone, Diane M	University Of California, San Diego United States	Biomarker Validation in Pancreatic Cystic Neoplasms	5U01CA282272-03	Matthew Young, Ph.D.